MetaCap

Cadre (CDRE) vs Enovis (ENOV)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.

Summary

Enovis (ENOV) has outperformed Cadre (CDRE) over the past year, losing 11.5% versus a loss of 26.8%. Over five years, CDRE leads with a +51.0% price change compared with -69.5% for ENOV. Enovis is the larger company by market cap ($1.47 billion vs $1.26 billion), about 1.2 times the size, while Cadre is growing revenue faster (+7.5% vs +6.7%).

On valuation, Enovis trades at a lower forward P/E (7.4x vs 18.5x for Cadre). Cadre pays a dividend yielding 1.34%, while Enovis does not currently pay one. Cadre converts more of its revenue into profit, with a net margin of 7.2% versus -52.7%.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

CDRE-26.83%ENOV-11.47%
+17%-12%-42%
Nov 21, 20251 yearNov 20, 2026
CDRE+41.11%ENOV-70.68%
+122%+17%-89%
Nov 15, 20215 yearsNov 16, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

CDRE versus ENOV key metrics
MetricCDREENOV
Share price$29.45$25.47
Market cap$1.26B$1.47B
1-day change-3.63%-2.90%
YTD return-27.89%-4.39%
1-year return-26.83%-11.47%
5-year return+51.03%-69.49%
P/E ratio (TTM)32.36—
Forward P/E18.537.35
EPS (TTM)$0.91$-9.23
Dividend yield1.34%0.00%
Annual dividend$0.395$0.00
Revenue (latest FY)$610.31M$2.25B
Revenue growth (YoY)+7.53%+6.66%
Net income (latest FY)$44.14M$-1.18B
Gross margin42.54%59.84%
Operating margin11.04%-50.01%
Net margin7.23%-52.69%
52-week high$48.76$31.67
52-week low$24.07$16.70
Distance from 52-week high-39.60%-19.58%
Analyst consensusstrong_buystrong_buy
Avg. price target upside+59.02%+48.53%
Average volume464.00K1.71M
Shares outstanding42.92M57.69M
Employees2,5337,802
SectorHealth CareHealth Care
IndustryIndustrial SpecialtiesIndustrial Specialties

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

Key differences

  • ENOV has outperformed CDRE by 15.4 percentage points over the past year.
  • Cadre offers a meaningfully higher dividend yield (1.34% vs 0.00%).
  • Cadre is more profitable, keeping 7.2 cents of every revenue dollar as net income versus -52.7 cents for Enovis.

About Cadre

CDRE stock →

Cadre Holdings, Inc. manufactures and distributes safety equipment and other related products that provides protection to users in hazardous or life-threatening situations in the United States and internationally.

Health Care · Industrial Specialties · 2,533 employees

About Enovis

ENOV stock →

Enovis Corporation, a medical technology company, focuses on developing clinically differentiated solutions in the United States and internationally. It operates through two segments: Prevention and Recovery, and Reconstructive segments.

Health Care · Industrial Specialties · 7,802 employees

CDRE vs ENOV FAQ

Which is bigger, Cadre or Enovis?

Enovis (ENOV) is larger, with a market capitalization of $1.47B compared with $1.26B for Cadre (CDRE).

Which stock has performed better over the past year, CDRE or ENOV?

ENOV returned -11.47% over the past 12 months, compared with -26.83% for CDRE (price return, excluding dividends). Past performance does not predict future results.

Which pays a higher dividend, Cadre or Enovis?

Cadre pays a dividend yielding 1.34%, while Enovis does not currently pay a regular dividend.

Are Cadre and Enovis in the same industry?

Yes. Both are classified in the Industrial Specialties industry within the Health Care sector.

More comparisons